Veterinary Medicines

Clavucill 200 mg + 50 mg 200 mg - 50 mg Tablet

Authorised
  • Amoxicillin trihydrate
  • POTASSIUM CLAVULANATE DILUTED WITH CELLULOSE, MICROCRYSTALLINE (1:1)
Download as PDF

Product identification

Medicine name:
Clavucill 200 mg + 50 mg 200 mg - 50 mg Tablet
Clavucill 200 mg+50 mg tabletter
Active substance:
  • Amoxicillin trihydrate
  • POTASSIUM CLAVULANATE DILUTED WITH CELLULOSE, MICROCRYSTALLINE (1:1)
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Amoxicillin trihydrate
    229.55
    milligram(s)
    /
    1.00
    Tablet
  • POTASSIUM CLAVULANATE DILUTED WITH CELLULOSE, MICROCRYSTALLINE (1:1)
    125.10
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01CA04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Denmark
Package description:
  • Clavucill 200 mg + 50 mg 200 mg - 50 mg tabl. 250
  • Clavucill 200 mg + 50 mg 200 mg - 50 mg tabl. 100
  • Clavucill 200 mg + 50 mg 200 mg - 50 mg tabl. 10

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 18 of Regulation (EU) 2019/6)
Marketing authorisation holder:
  • V.M.D.
Marketing authorisation date:
Manufacturing sites for batch release:
  • V.M.D.
Responsible authority:
  • Danish Medicines Agency
Authorisation number:
  • 48710
Date of authorisation status change:
Reference member state:
  • Belgium
Procedure number:
  • BE/V/0024/002
Concerned member states:
  • Denmark
  • France
  • Germany
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Spain
  • Sweden
Generic of:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Danish (PDF)
Published on: 29/06/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."